B3SA3:BMFBOVESPAB3 SA - Brasil, Bolsa, Balcao Analysis
Data as of 2026-05-28 - not real-time
R$16.17
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
B3 S.A. trades at 16.17 BRL, well below its DCF fair value of 27.25 BRL, indicating substantial upside. The stock offers a 3.68% dividend yield with a payout ratio of 66%, supported by robust operating cash flow of 6.56 bn BRL. Revenue grew 20% YoY to 10.55 bn BRL and margins remain exceptionally high (gross 95%, operating 67%). Analyst consensus of 14 forecasts a mean target of 20.04 BRL, implying ~24% upside. Technicals show the 20‑day SMA (17.15) above the 50‑day SMA (17.89) and price sits just above the identified support at 15.81, while MACD is slightly bearish and RSI at 38 suggests modest downside pressure. Volatility over the past 30 days is 35%, and beta of 1.3 signals higher sensitivity to market moves.
The sector—financial data and exchanges—carries moderate regulatory exposure, but B3’s dominant market position mitigates competitive risk. Brazil’s macro environment adds geographic and currency considerations, yet the company’s strong balance sheet (cash 14.98 bn, debt 15.58 bn) provides a cushion. The dividend yield is attractive relative to peers, and the payout appears sustainable given free cash flow of 4.55 bn BRL. Analyst recommendation is a “buy” with a mean target above current levels. Given the combination of undervaluation, solid fundamentals, and dividend appeal, the stock is positioned for upside in the coming months. Investors should monitor regulatory developments and macro volatility, but the current risk‑adjusted profile remains favorable.
The sector—financial data and exchanges—carries moderate regulatory exposure, but B3’s dominant market position mitigates competitive risk. Brazil’s macro environment adds geographic and currency considerations, yet the company’s strong balance sheet (cash 14.98 bn, debt 15.58 bn) provides a cushion. The dividend yield is attractive relative to peers, and the payout appears sustainable given free cash flow of 4.55 bn BRL. Analyst recommendation is a “buy” with a mean target above current levels. Given the combination of undervaluation, solid fundamentals, and dividend appeal, the stock is positioned for upside in the coming months. Investors should monitor regulatory developments and macro volatility, but the current risk‑adjusted profile remains favorable.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Price near support with limited downside
- Attractive dividend yield
- Undervaluation versus DCF fair value
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Analyst price target implying ~24% upside
- Strong revenue growth and high margins
- Sustainable cash flow supporting dividend
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Long‑term DCF fair value far above current price
- Dominant market position in Brazil's exchange infrastructure
- Consistent profitability and solid balance sheet
Key Metrics & Analysis
Financial Health
Revenue Growth20.30%
Profit Margin46.97%
P/E Ratio17.6
ROE26.74%
ROA9.24%
Debt/Equity85.24
P/B Ratio4.4
Op. Cash FlowR$6.6B
Free Cash FlowR$4.6B
Industry P/E16.6
Technical Analysis
TrendNeutral
RSI38.3
SupportR$15.81
ResistanceR$18.59
MA 20R$17.15
MA 50R$17.89
MA 200R$15.24
MACDBearish
VolumeStable
Fear & Greed Index92
Valuation
Fair ValueR$27.25
Target PriceR$20.04
Upside/Downside23.91%
GradeUndervalued
TypeBlend
Dividend Yield3.68%
Risk Assessment
Beta1.30
Volatility35.10%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.